|
|
Volumn 13, Issue 3-4, 2004, Pages 238-248
|
|
Drug development in the 21st century: Medicines, man and receptors
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
AVASTATIN;
ENZYME;
GEFITINIB;
IMATINIB;
ION CHANNEL;
LIGAND;
MERCAPTOPURINE;
MIBEFRADIL;
RECEPTOR;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
CONFERENCE PAPER;
COST BENEFIT ANALYSIS;
DRUG DESIGN;
DRUG DEVELOPMENT;
DRUG RESEARCH;
DRUG TARGETING;
GENOMICS;
HEALTH CARE DELIVERY;
HUMAN;
MOLECULAR BIOLOGY;
NONHUMAN;
PHARMACEUTICAL ENGINEERING;
SIGNAL TRANSDUCTION;
|
|
EID: 10644287715
PISSN: 10542523
EISSN: None
Source Type: Journal
DOI: 10.1007/s00044-004-0031-9 Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (0)
|
